IL-19 belongs to the IL-10 family, which includes IL-10, IL-19, IL-20, IL-22, melanoma differentiation-associated gene-7 (IL-24), and AK155 (IL-26). IL-10 has been shown to inhibit allergen-induced airway hyperreactivity and inflammation. To determine whether IL-19 was also associated with asthma, we used ELISA to analyze the serum level of IL-19 in patients with asthma and found that their serum IL-19 levels were twice those of healthy controls. Patients with a high level of IL-19 also had high levels of IL-4 and IL-13. In a dust mite-induced murine model of asthma, we found that IL-19 level in asthmatic BALB/cJ mice was also twice that of healthy control mice. IL-19 transcript was also induced in the lungs of asthmatic mice. Electroporation i.m. of the IL-19 gene into healthy mice up-regulated IL-4 and IL-5, but not IL-13. However, IL-19 up-regulated IL-13 in asthmatic mice. In vitro, IL-19 induced IL-4, IL-5, IL-10, and IL-13 production by activated T cells. Activation of T cells was required for induction of IL-13 because IL-19 did not induce IL-13 production on nonstimulated T cells. Taken together, these results demonstrated that IL-19 up-regulates Th2 cytokines on activated T cells and might play an important role in the pathogenesis of asthma.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.4049/jimmunol.173.11.6712 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Higher Intraocular Levels of Inflammatory Factors are Related to Retinal Vascular and Neurodegeneration in Myopic Retinopathy.
J Inflamm Res
December 2024
Aier Academy of Ophthalmology, Central South University, Changsha, People's Republic of China.
Purpose: In this study, we aimed to investigate the relationship between the intraocular levels of inflammatory factors and myopia-related retinal vascular and neuronal degeneration.
Patients And Methods: One hundred and forty-seven patients with Implantable Collamer Lens (ICL) implantation were enrolled and all participants received comprehensive ophthalmic examination. About 100~150 ul of aqueous humor was collected immediately before ICL surgery.
Circulating CD31 and resistin levels reflect different stages of coronary atherosclerosis in patients with psoriasis.
J Dermatol
January 2025
Department of Dermatology, Kansai Medical University, Osaka, Japan.
Article Synopsis
- Psoriasis, a complicated skin condition linked to inflammation, has unclear connections between its severity, related cytokine levels, and heart disease risk.
- This study aimed to identify serum markers to help monitor cardiovascular disease (CVD) risk in psoriasis patients by examining relationships between cytokines and coronary artery health.
- Key findings highlight that specific cytokines (IL-17A, IL-19, IL-36) correlate with psoriasis severity, while markers like CD31 and resistin show promise for tracking coronary atherosclerosis progression, particularly in patients with psoriasis vulgaris.
Pharmacodynamic Response to Deucravacitinib, an Oral, Selective, Allosteric TYK2 Inhibitor, in a Global, Phase 2, Randomized, Double-Blind, Placebo-Controlled Psoriasis Trial.
Dermatol Ther (Heidelb)
October 2024
The Rockefeller University, New York, NY, USA.
Background: Psoriasis, a chronic, immune-mediated, inflammatory disease, affects 2‒3% of the population. Tyrosine kinase 2 (TYK2) mediates cytokine signaling involved in adaptive [interleukin (IL)-12, IL-23] and innate (type-I interferons) immune responses; IL-23-driven T-helper (Th)17 pathways play a key role in chronic inflammation in psoriasis. In a phase 2 trial, deucravacitinib, an oral, selective, allosteric TYK2 inhibitor, reduced IL-23/Th17 and type-I interferon pathway expression in the skin of patients with moderate to severe plaque psoriasis, reductions that were accompanied by clinical improvement of psoriatic lesions.
View Article and Find Full Text PDFBlack Phosphorus Nanosheets-Based Hydrogel for Efficient Bacterial Inhibition and Accelerating Wound Healing.
ACS Appl Mater Interfaces
August 2024
Chinese PLA Medical School & Chinese PLA General Hospital, Beijing 100853, China.
Article Synopsis
- A thermosensitive hydrogel made with chitosan and black phosphorus nanosheets was created to combat multidrug-resistant bacteria and improve wound healing.
- This hydrogel delivers an angiogenic drug, deferoxamine mesylate (DFO), which helps speed up cell migration and blood vessel formation.
- When treated with near-infrared light, the hydrogel effectively kills bacteria and promotes a healing environment by boosting anti-inflammatory responses in macrophages.
Immunohistochemical Analysis of IL-19 and IL-24 Expression in Inflammatory Bowel Disease (IBD) Patients: Results From a Single Center Retrospective Study.
Cureus
July 2024
Histology and Embryology, Aristotele University of Thessaloniki, Thessaloniki, GRC.
Article Synopsis
- The study investigated the expression levels of IL-19 and IL-24 in patients with inflammatory bowel disease (IBD) compared to healthy controls, and how these levels change before and after biologic treatment.
- Researchers measured IL-19 and IL-24 in intestinal tissue samples from 121 IBD patients and found elevated levels in IBD patients, with IL-19 being linked to disease activity after treatment.
- The findings suggest that both IL-19 and IL-24 play significant roles in the inflammation associated with IBD and could potentially serve as biomarkers for tracking disease activity and treatment response.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!